" class="no-js "lang="en-US"> Immunology Archives - Page 7 of 11 - Medtech Alert
Friday, October 03, 2025

Sort by:

Date

Top Post

INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect […]

Degron Therapeutics Co-Founder Provides New Strategy for Molecular Glue in Tumor Immunotherapy

Degron Therapeutics (“Degron”), a biotechnology company developing a new class of small-molecule medicines that target […]

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and […]

GSK Presents Promising New Data for Bepirovirsen, an Investigational Treatment for Chronic Hepatitis B

GSK plc today announced promising interim results from the B-Clear phase IIb trial showing that […]

Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH

Echosens, a high-technology company offering liver diagnostic solutions, and Novo Nordisk A/S, a leading global […]

Targovax Announces That the FDA Has Granted Authorization to Initiate Clinical Trials With the Enhanced TG01 RAS Vaccine in the USA

Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid […]

Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy

Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emercell) announced today the recent exercise of […]

Sanofi-GSK Next-generation COVID-19 Booster Delivers Strong Immune Response Against Variants of Concern, Including Omicron

Sanofi today reports data from two trials, VAT02 Cohort 2 and COVIBOOST VAT013, conducted with […]

Endo Tools Therapeutics Receives Positive Opinion From French High Authority for Health on Forfait Innovation Scheme to Treat Patients With Diabetes

Endo Tools Therapeutics (ETT), a company developing advanced endoscopic medical devices, today announces that HAS, […]

Cancer Vaccine Biotech CimCure Raises € 5 Million in Seed Round Investment Led by Positron Ventures

CimCure, a biotech spin-off of Amsterdam UMC, focusing on the development of a novel vaccine-based […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more